This fusion reduces the CCDC6-mediated inhibition of CREB1, resulting in increased CREB1 activity and the upregulation of its target genes, such as AREG and cyclin A, thereby promoting thyroid tumorigenesis [59]. The gene discussed is CREB1; the disease is thyroiditis.